Select Bibliography

Filter by any of these (after searching):

CALGB-70305

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 7 items

Effects of a lymphedema prevention intervention on range of motion among women receiving axillary node dissection for breast cancer treatment (Alliance) CALGB 70305

Armer, Jane M , Liu, Heshan , Oliveri, Jill , Seisler, Drew , tbd ... - ASCO CSS - J Clin Oncol - 2018

Abstract - Secondary - Primary - Symptom Inter - CALGB-70305

Health-related quality of life outcomes for the LEAP Study - Alliance 70305: a lymphedema prevention intervention trial for newly-diagnosed breast cancer patients

Naughton, MJ , Seisler, DK , Sloan, JA , Liu, H , Le-Rademacher, J ... - ISOQOL - Qual Life Res - 2018

Abstract - Secondary - Primary - Health Outcomes - CALGB-70305

Health-Related Quality of Life Outcomes for the LEAP Study - CALGB 70305 (Alliance): A Lymphedema Prevention Intervention Trial for Newly Diagnosed Breast Cancer Patients

Naughton, Michelle J. , Liu, Heshan , Seisler, Drew ... - - Cancer - 2021

Manuscript - Secondary - Primary - Health Outcomes - CALGB-70305

A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance)

Paskett, Electra D. , Le-Rademacher, Jennifer , Oliveri, Jill M. ... - - Cancer - 2021

Manuscript - Primary - Primary - Symptom Inter - CALGB-70305

The LEAP Study: Effects of a lymphedema prevention intervention on swelling, range of motion and quality of life (Alliance)

Paskett, Electra D. , Le-Rademacher, Jennifer , Oliveri, Jill ... - IPOS - Psycho-Oncol - 2018

Abstract - Primary - Primary - Symptom Inter - CALGB-70305

Effects of a lymphedema prevention intervention on range of motion among women receiving lymph node dissection for breast cancer treatment (Alliance) CALGB 70305.

Paskett, Electra D. , Liu, Heshan , Oliveri, Jill , Seisler, Drew K. ... - ILF - JCO - 2018

Abstract - Secondary - Primary - Symptom Inter - CALGB-70305

Prevention of Lymphedema in Women with Breast Cancer: Results of CALGB 70305 (Alliance)

Paskett, Electra , Oliveri, Jill , Le-Rademacher, Jennifer ... - ASCO CSS - J Clin Oncol - 2017

Abstract - Primary - Primary - Symptom Inter - CALGB-70305